2023

• Gupta, R., Selinger, C., Ashford, B., Chua, M., Clark, J., Damian, D., Jackett, L., James, C., Johnson, S., Ladwa, R., McKenzie, C., Scolyer, R., et al (2023). Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations. Pathology, 55(6), 743-759. [More Information]
• Allen, N., Martin, A., Snaidr, V., Eggins, R., Chong, A., Fernandez Penas, P., Gin, D., Sidhu, S., Paddon, V., Banney, L., Lim, A., McKenzie, C., Scolyer, R., Dhillon, H., Vardy, J., Chadban, S., Bowen, D., Chen, A., Damian, D., et al (2023). Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. New England Journal of Medicine, 388(9), 804-812. [More Information]
• Zilberg, C., Lyons, J., Gupta, R., Damian, D. (2023). The Immune Microenvironment in Basal Cell Carcinoma. Annals of Dermatology, 35(4), 243-255. [More Information]
• Zilberg, C., Lyons, J., Gupta, R., Ferguson, A., Damian, D. (2023). The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients. Annals of Dermatology, 35(2), 91-99. [More Information]

2022

• Allen, N., Damian, D. (2022). Interventions to Increase Sunscreen Use in Adults: A Review of the Literature. Health Education and Behavior, 49(3), 415-423. [More Information]
• Zilberg, C., Paver, E., Damian, D. (2022). Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient. Case Reports in Dermatology, 14(2), 127-131. [More Information]
• Blazek, K., Furestad, E., Ryan, D., Damian, D., Fernandez Penas, P., Tong, S. (2022). The impact of skin cancer prevention efforts in New South Wales, Australia: Generational trends in melanoma incidence and mortality. Cancer Epidemiology, 81. [More Information]

2021

• Pham, J., Star, P., Wong, S., Damian, D., Saw, R., Whitfeld, M., Menzies, A., Joshua, A., Smith, A. (2021). Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor. Skin Health and Disease, 1(4). [More Information]

2020

• Malesu, R., Martin, A., Lyons, J., Scolyer, R., Chen, A., McKenzie, C., Madore, J., Halliday, G., Damian, D. (2020). Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma: In vitro and in vivo. Photochemical & Photobiological Sciences, 19(2), 171-179. [More Information]

2019

• Minocha, R., Martin, A., Chen, A., Scolyer, R., Lyons, J., McKenzie, C., Madore, J., Halliday, G., Damian, D. (2019). A reduction in inflammatory macrophages may contribute to skin cancer chemoprevention by nicotinamide. Journal of Investigative Dermatology, 139(2), 467-469. [More Information]
• Martin, A., Dhillon, H., Vardy, J., Dalziell, R., Choy, B., Fernandez Penas, P., Dixon, A., Renton, C., St George, G., Chinniah, N., Halliday, G., Damian, D., Chen, A. (2019). Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide. Geriatrics, 4(1), 1-6. [More Information]
• Snaidr, V., Damian, D., Halliday, G. (2019). Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety. Experimental Dermatology, 28(S1), 15-22. [More Information]

2018

• Shashank, A., Guminski, A., Abu Alrub, N., Scolyer, R., Damian, D., Thompson, J. (2018). Basal Cell Carcinoma. In S. Morita, C. Balch, V. Klimberg, T. Pawlik, M. Posner, & K. Tanabe (Eds.), Textbook of Complex General Surgical Oncology, (pp. 219-227). New York: McGraw-Hill Education.
• Minocha, R., Damian, D., Halliday, G. (2018). Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? Photodermatology, Photoimmunology & Photomedicine, 34(1), 5-12. [More Information]

2017

• Damian, D. (2017). Nicotinamide for skin cancer chemoprevention. Australasian Journal of Dermatology, 58(3), 174-180. [More Information]
• Damian, D., Martin, A., Scolyer, R., Chen, A., Halliday, G. (2017). Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors. British Journal of Dermatology, 176(2), 552-553. [More Information]

2016

• Chen, A., Martin, A., Dalziell, R., McKenzie, C., Lowe, P., Eris, J., Scolyer, R., Dhillon, H., Vardy, J., Bielski, V., Halliday, G., Damian, D. (2016). A Phase II Randomised Controlled Trial of Nicotinamide for Skin Cancer Chemoprevention in Renal Transplant Recipients. British Journal of Dermatology, 175(5), 1073-1075. [More Information]
• McKenzie, C., Chen, A., Choy, B., Fernandez Penas, P., Damian, D., Scolyer, R. (2016). Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting. Pathology, 48(5), 395-397. [More Information]
• Chen, A., Martin, A., Dalziell, R., Halliday, G., Damian, D. (2016). Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial. British Journal of Dermatology, 175(6), 1363-1365. [More Information]
• Chen, A., Martin, A., Damian, D. (2016). The authors reply: Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 374(8), 789-790. [More Information]

2015

• Chen, A., Martin, A., Choy, B., Fernandez Penas, P., Dalziell, R., McKenzie, C., Scolyer, R., Dhillon, H., Vardy, J., Kricker, A., St George, G., Chinniah, N., Halliday, G., Damian, D. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 373(17), 1618-1626. [More Information]
• Rennie, G., Chen, A., Dhillon, H., Vardy, J., Damian, D. (2015). Nicotinamide and neurocognitive function. Nutritional Neuroscience, 18(5), 193-200. [More Information]
• Thompson, B., Halliday, G., Damian, D. (2015). Nicotinamide enhances repair of arsenic and ultraviolet radiation-induced DNA damage in HaCaT keratinocytes and ex vivo human skin. PloS One, 10(2), 1-13. [More Information]
• Kim, B., Halliday, G., Damian, D. (2015). Oral Nicotinamide and Actinic Keratosis: A Supplement Success Story. In H. Peter Soyer, Tarl W. Prow, Gregor B.E. Jemec (Eds.), Actinic Keratosis, (pp. 143-149). Basel: S. Karger AG. [More Information]

2014

• Chen, A., Damian, D. (2014). Nicotinamide and the skin. Australasian Journal of Dermatology, 55(3), 169-175. [More Information]
• Halliday, G., Damian, D., Surjana, D. (2014). Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes. Experimental Dermatology, 23(7), 509-511. [More Information]
• Chen, A., Damian, D., Halliday, G. (2014). Oral and systemic photoprotection. Photodermatology, Photoimmunology & Photomedicine, 30(2-3), 102-111. [More Information]
• Song, E., Scolyer, R., Damian, D., Thompson, J. (2014). Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology, 12(1), 77-77. [More Information]
• Damian, D., Saw, R., Thompson, J. (2014). Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma. Journal of Surgical Oncology, 109(4), 308-313. [More Information]

2013

• Song, E., Gordon-Thomson, C., Cole, L., Stern, H., Halliday, G., Damian, D., Reeve, V., Mason, R. (2013). 1alpha,25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 131-138. [More Information]
• Surjana, D., Halliday, G., Damian, D. (2013). Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis, 34(5), 1144-1149. [More Information]
• Chen, A., Halliday, G., Damian, D. (2013). Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology, 45(3), 331-341. [More Information]
• Cho, E., Moloney, F., Cai, H., Au-Yeung, A., China, C., Scolyer, R., Yosuï¬�, B., Raftery, M., Deng, J., Morton, S., Damian, D., Barnetson, R., Halliday, G., et al (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet, 381(9880), 1835-1843. [More Information]

2012

• Thanos, S., Halliday, G., Damian, D. (2012). Nicotinamide Reduces Photodynamic Therapy-Induced Immunosuppression In Humans. British Journal of Dermatology, 167(3), 631-636. [More Information]
• Surjana, D., Halliday, G., Martin, A., Moloney, F., Damian, D. (2012). Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials. Journal of Investigative Dermatology, 132(5), 1497-1500. [More Information]
• Halliday, G., Damian, D., Rana, S., Byrne, S. (2012). The suppressive effects of ultraviolet radiation on immunity in the skin and internal organs: Implications for autoimmunity. Journal of Dermatological Science, 66(3), 176-182. [More Information]

2011

• Damian, D., Matthews (nee Renwick), Y., Phan, T., Halliday, G. (2011). An action spectrum for ultraviolet radiation-induced immunosuppression in humans. British Journal of Dermatology, 164(3), 657-659. [More Information]
• Damian, D., Saw, R. (2011). Dramatic regression of cutaneous, nodal, and visceral melanoma metastases. Journal Of The American Academy Of Dermatology, 65(3), 665-666. [More Information]
• Surjana, D., Damian, D. (2011). Nicotinamide in dermatology and photoprotection. Skinmed, 9(6), 360-365. [More Information]
• Frost, G., Halliday, G., Damian, D. (2011). Photodynamic Therapy-Induced Immunosuppression in Humans Is Prevented by Reducing the Rate of Light Delivery. Journal of Investigative Dermatology, 131(4), 962-968. [More Information]
• Damian, D., Thompson, J. (2011). Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg. American Journal of Clinical Dermatology, 12(6), 403-404. [More Information]
• Kurien, A., Damian, D., Moloney, F. (2011). Trigeminal trophic syndrome treated with thermoplastic occlusion. Australasian Journal of Dermatology, 52(1), e1-e4. [More Information]
• Halliday, G., Byrne, S., Damian, D. (2011). Ultraviolet A Radiation: Its Role in Immunosuppression and Carcinogenesis. Seminars in Cutaneous Medicine and Surgery, 30(4), 214-221. [More Information]

2010

• Damian, D., Bertouch, J. (2010). A Plethora of Protein. The American Journal of Medicine, 123(10), 904-906. [More Information]
• Matthews (nee Renwick), Y., Halliday, G., Phan, T., Damian, D. (2010). A UVB Wavelength Dependency for Local Suppression of Recall Immunity in Humans Demonstrates a Peak at 300 nm. Journal of Investigative Dermatology, 130(6), 1680-1684. [More Information]
• Park, J., Halliday, G., Surjana, D., Damian, D. (2010). Nicotinamide Prevents Ultraviolet Radiation-induced Cellular Energy Loss. Photochemistry and Photobiology, 86(4), 942-948. [More Information]
• Damian, D. (2010). Photoprotective effects of nicotinamide. Photochemical & Photobiological Sciences, 9(4), 578-585. [More Information]
• Moloney, F., Vestergaard, M., Radojkovic, B., Damian, D. (2010). Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses. British Journal of Dermatology, 162(5), 1138-9. [More Information]
• Christou, E., Damian, D., Thompson, J. (2010). Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian. Medical Journal of Australia, 192(3), 171. [More Information]
• Halliday, G., Surjana, D., Damian, D. (2010). Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. Journal of Nucleic Acids, 2010 (157591), 1-13. [More Information]
• Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010). TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology: new methods and technology, 9(11), 1368-1372. [More Information]
• Damian, D., Kim, Y., Dixon, K., Halliday, G., Javeri, A., Mason, R. (2010). Topical calcitriol protects from UV-induced genetic damage but suppresses cutaneous immunity in humans. Experimental Dermatology, 19(8), e23-e30. [More Information]
• Matthews (nee Renwick), Y., Damian, D. (2010). Topical photodynamic therapy is immunosuppressive in humans. British Journal of Dermatology, 162(3), 637-641. [More Information]
• Damian, D., Matthews (nee Renwick), Y., Halliday, G. (2010). Topical riboflavin attenuates ultraviolet B- and ultraviolet A-induced immunosuppression in humans. Photodermatology, Photoimmunology & Photomedicine, 26(2), 66-69. [More Information]
• Matthews (nee Renwick), Y., Halliday, G., Phan, T., Damian, D. (2010). Wavelength dependency for UVA-induced suppression of recall immunity in humans. Journal of Dermatological Science, 59(3), 192-197. [More Information]

2009

• Yiasemides, E., Sivapirabu, G., Halliday, G., Park, J., Damian, D. (2009). Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis, 30(1), 101-105. [More Information]
• Damian, D., Shannon, K., Thompson, J. (2009). Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australasian Journal of Dermatology, 50(4), 266-271. [More Information]
• Sivapirabu, G., Yiasemides, E., Halliday, G., Park, J., Damian, D. (2009). Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. British Journal of Dermatology, 161(6), 1357-1364. [More Information]
• de Zwaan, S., Iland, H., Damian, D. (2009). Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. Australasian Journal of Dermatology, 50(1), 56-59. [More Information]
• Damian, D., Yue, D., Gupta, S., Armour, K. (2009). Ultrasound therapy for lipodermatosclerosis. Archives of Dermatology, 145(3), 330-2. [More Information]
• McCombie, A., Mason, R., Damian, D. (2009). Vitamin D deficiency in Sydney skin cancer patients. Medical Journal of Australia, 190(2), 102. [More Information]

2008

• Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).
• Wiener, M., Damian, D., Thompson, J. (2008). Systemic phototoxicity following intralesional rose bengal for subcutaneous melanoma metastases. Dermatology, 216(4), 361-362. [More Information]
• Damian, D., Patterson, C., Stapelberg, M., Park, J., Barnetson, R., Halliday, G. (2008). UV Radiation-Induced Immunosuppression Is Greater in Men and Prevented by Topical Nicotinamide. Journal of Investigative Dermatology, 128(2), 447-454. [More Information]

2007

• Matthews (nee Renwick), Y., Phan, T., Halliday, G., Damian, D. (2007). Comparison of the immune suppressive effectiveness of UVB and long-wave UVA in humans. Australasian Society for Dermatology Research Meeting 2007, United Kingdom: Nature Publishing Group.
• Halpagi, P., Grigg, J., Klistorner, A., Damian, D. (2007). Night blindness following low-dose isotretinoin. Journal of the European Academy of Dermatology and Venereology, 22(7), 893-894. [More Information]
• Damian, D., Thompson, J. (2007). Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone. Journal Of The American Academy Of Dermatology, 56(5), 869-871. [More Information]

2006

• Howes, R., Halliday, G., Damian, D. (2006). Effect of topical melatonin on ultraviolet radiation-induced suppression of Mantoux reactions in humans. Photodermatology, Photoimmunology & Photomedicine, 22(5), 267-269. [More Information]
• Herat, A., Shirato, K., Damian, D., Finlayson, R., Whitfeld, M. (2006). Invasive squamous cell carcinoma arising in refractory perianal Bowen's disease in a HIV-positive individual. Australasian Journal of Dermatology, 47(2), 120-123. [More Information]
• Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband. Photodermatology, Photoimmunology & Photomedicine, 22(4), 174-180. [More Information]
• Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Spectral and dose dependence of ultraviolet radiation-induced immunosuppression. Frontiers in Bioscience, 11, 394-411. [More Information]
• Howes, R., Halliday, G., Barnetson, R., Friedmann, A., Damian, D. (2006). Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans. Journal of Dermatological Science, 44, 113-115. [More Information]
• Damian, D., Barnetson, R., Thompson, J. (2006). Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. Journal of Cutaneous Medicine and Surgery, 10(1), 48-51. [More Information]

2005

• Patterson, C., Halliday, G., Barnetson, R., Damian, D. (2005). Effect of topical nicotinamide (vitamin B3) on ultraviolet radiation-induced immunosuppression in humans. Australasian Journal of Dermatology, 46(1), A10-A11.

2004

• Friedmann, A., Halliday, G., Barnetson, R., Reeve, V., Walker, C., Patterson, C., Damian, D. (2004). The Topical Isoflavonoid Nv-07Alpha Reduces Solar-Simulated Uv-Induced Suppression Of Mantoux Reactions In Humans. Photochemistry and Photobiology, 80(3), 416-421. [More Information]

2003

• Damian, D., Rogers, M. (2003). Demodex infestation in a child with leukaemia: treatment with ivermectin and permethrin. International Journal Of Dermatology, 42(9), 724-726. [More Information]

2002

• Halliday, G., Poon, T., Damian, D., Barnetson, R. (2002). Immune protection factor of sunscreens in humans is dependent on protection from UVA and cannot be predicted from the sun protection factor. Journal of Photoscience, 9, 236-239.
• Damian, D., Halliday, G. (2002). Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods, 28(1), 34-45. [More Information]